Diagnostic performance of [18F]FDG PET/CT in large vessel vasculitis management: an umbrella review

Maria Del Grande1, Chiara Martinello2, Giorgio Treglia2,3,4

  • 1Department of Rheumatology, University Hospital Basel, Basel, Switzerland - maria.delgrande@usb.ch.

Insights

[18F]FDG PET/CT is a highly accurate, non-invasive tool for diagnosing large vessel vasculitis (LVV), including giant cell arteritis (GCA) and Takayasu arteritis (TAK). This imaging technique shows promise in monitoring treatment effectiveness for LVV.

Area of Science:

  • Nuclear medicine
  • Radiology
  • Rheumatology

Background:

  • Large vessel vasculitis (LVV), including GCA, TAK, and PMR, causes significant morbidity by affecting large arteries.
  • Accurate diagnosis of LVV is challenging with conventional methods like biopsy or CT/MRI.
  • [18F]FDG PET/CT offers a non-invasive approach to assess arterial inflammation in LVV.

Purpose of the Study:

  • To evaluate the diagnostic performance of [18F]FDG PET/CT in managing large vessel vasculitis (LVV).
  • To assess the utility of [18F]FDG PET/CT in identifying active inflammation in LVV patients.

Main Methods:

  • An umbrella review of systematic reviews and meta-analyses was conducted.
  • Searches were performed in major databases (PubMed/MEDLINE, Embase, Cochrane, Scopus, Web of Science) up to February 2025.
  • Data extraction and quality assessment followed the Oxford Center for Evidence-Based Medicine criteria.

Main Results:

  • Thirteen systematic reviews confirmed [18F]FDG PET/CT's high sensitivity (75.9-90%) and specificity (71-98%) for active LVV detection.
  • The technique demonstrated superior performance over CT/MRI in identifying extracranial inflammation, particularly in GCA and TAK.
  • [18F]FDG PET/CT showed potential for monitoring treatment response in LVV.

Conclusions:

  • [18F]FDG PET/CT is a valuable diagnostic tool for LVV, offering high accuracy and clinical utility.
  • Emerging technologies like LAFOV scanners, novel radiotracers, and advanced MRI techniques are advancing diagnostic precision.
  • Standardized protocols are needed for optimal integration of [18F]FDG PET/CT into clinical practice for LVV management.
Abstract